✦ LIBER ✦

Cost-Utility Analysis of Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis in Iran

✍ Scribed by Imani, A. (author);Golestani, M. (author);Tabrizi, J.S. (author);Janati, A. (author)

Book ID: 122266811
Publisher: Elsevier BV
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.1833

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Utility Analysis of Disease-Modifyi

Cost-Utility Analysis of Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis in Iran

✍ Imani, A. (author);Golestani, M. (author);Tabrizi, J.S. (author);Janati, A. (aut 📂 Article 📅 2013 🏛 Elsevier BV 🌐 English ⚖ 60 KB

Cost-Analysis of Relapsing-Remitting Mul

Cost-Analysis of Relapsing-Remitting Multiple Sclerosis in Italy after the Introduction of New Disease-Modifying Agents

✍ Dr Pierluigi Russo, Alessandro Capone, Andrea Paolillo, Francesco Macchia, Feder 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 137 KB

Cost of care according to disease-modify

Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis

✍ Miguel A. Macías-Islas, Isaac F. Soria-Cedillo… 📂 Article 📅 2013 🏛 Royal Association of Belgian Medical Scientific So 🌐 English ⚖ 328 KB

PRS28 COST-UTILITY ANALYSES OF DISEASE-M

PRS28 COST-UTILITY ANALYSES OF DISEASE-MODIFYING THERAPIES FOR PATIENTS WITH RELAPSE-REMITTING MULTIPLE SCLEROSIS IN THE UNITED STATE

✍ M Yang; WW Tseng; SS Sansgiry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PND1 ASSESSING THE NET CLINICAL BENEFIT

PND1 ASSESSING THE NET CLINICAL BENEFIT AND ABSOLUTE RISK REDUCTION OF DISEASE MODIFYING DRUGS IN RELAPSING REMITTING MULTIPLE SCLEROSIS

✍ A AL-Sabbagh; R Bennett; R Glanzman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PNR1: COST-EFFECTIVENESS AND COST-UTILIT

PNR1: COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF INTERFERON BETA-IB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN POLAND (2-YEARS PERSPECTIVE)

✍ E Orlewska; P Mierzejewski; A Czlonkowska 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB